Advertisement
Screener

PULMONX CORPORATION (LUNG) Deferred Tax Liabilities, Gross

2.8 / 5 stars · 68/120 Roast Me

PULMONX CORPORATION Deferred Tax Liabilities, Gross

PULMONX CORPORATION (LUNG) had Deferred Tax Liabilities, Gross of $4.73 million as of 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-10

  • 2025-12-31: Deferred Tax Liabilities, Gross $4.73M.
  • 2024-12-31: Deferred Tax Liabilities, Gross $4.95M.
  • 2023-12-31: Deferred Tax Liabilities, Gross $1.28M.
Period endDeferred Tax Liabilities, Gross
2025-12-31$4.73M
10-K · filed 2026-03-10
2024-12-31$4.95M
10-K · filed 2026-03-10
2023-12-31$1.28M
10-K · filed 2025-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B